A portable and inflatable patient isolation chamber and stretcher system having an exoskeletal frame, which when inflated, forms a substantially tent contour enclosure when coupled to an inflatable flexible base. The exoskeletal frame has an apex section formed by a flexible apex conduit which is coupled to and in fluid communication with first and second flexible end conduits. The inflatable flexible base is connected to the exoskeletal frame and is in fluid communication with the exoskeletal frame for providing a flexible platform for the patient. A transparent envelope is secured to the exoskeletal frame and inflatable flexible base for forming a patient isolation chamber. When deflated, the flexible base can serve as a stretcher for transport of the patient.

A DAP unweighting system for unweighting a user while using an exercise machine is provided that includes an unweighting assembly having a substantially airtight chamber formed about at least a portion of the exercise machine that includes a user seal for encapsulating a portion of the user, and at least one additional frame member for securing to the exercise machine frame element to secure the chamber to the exercise machine. The exercise machine can include a treadmill having a belt extending a belt length in a longitudinal direction of the unweighting system The at least one additional frame member can have a frame member length less than the belt length that can be oriented substantially parallel with the belt when securing the chamber to the treadmill.

The present disclosure relates to a booth-type mobile infectious disease clinic, and more particularly, to a mobile infectious disease clinic, which is a booth-type mobile infectious disease clinic which makes it possible to assemble and disassemble a large number of mobile infectious disease clinics, that allows a test subject to be tested by a healthcare provider using an infectious disease test kit while exposure of the body parts is minimized and the healthcare provider and the test subject are isolated in the booth-type mobile infectious disease clinic, that performs sterilization of an infectious disease using an ultraviolet C (UV-C) lamp to reduce the time taken for disinfecting the clinic, and that allows the light radiation intensity of the UV-C lamp to be adaptively adjusted according to the body temperature of the test subject.

The CPAP enclosure is for use in treating sleep apnea in a patient. The CPAP enclosure creates a protected space that contains atmospheric gases at an increased pressure. The increased pressure created within the protected space of the CPAP enclosure prevents the narrowing of the patient's breathing airways during sleep. The CPAP enclosure includes a tent, a valve structure, and a CPAP machine. The tent forms the protected space of the CPAP enclosure. The CPAP machine generates a flow of atmospheric gas under pressure that is pumped into the protected space of the CPAP enclosure. The valve structure controls the flow of atmospheric gas under pressure from the CPAP machine into the protected space of the CPAP enclosure. The valve structure controls the pressure of the atmospheric gas contained within the protected space of the CPAP enclosure.

The CPAP enclosure is for use in treating sleep apnea in a patient. The CPAP enclosure creates a protected space that contains atmospheric gases at an increased pressure. The increased pressure created within the protected space of the CPAP enclosure prevents the narrowing of the patient's breathing airways during sleep. The CPAP enclosure includes a tent, a valve structure, and a CPAP machine. The tent forms the protected space of the CPAP enclosure. The CPAP machine generates a flow of atmospheric gas under pressure that is pumped into the protected space of the CPAP enclosure. The valve structure controls the flow of atmospheric gas under pressure from the CPAP machine into the protected space of the CPAP enclosure. The valve structure controls the pressure of the atmospheric gas contained within the protected space of the CPAP enclosure.

The present invention relates to an adaptive hyperbaric oxygen chamber designed to function as a medical apparatus in order to treat a subject suffering from any FDA approved medical condition. The hyperbaric oxygen chamber is designed and constructed in such a way that only one subject can be allowed to sit in an upright seated position, unless a pediatric seat is occupied by a pediatric patient and an adult is seated in the standard seat to accompany the pediatric patient. The upright patient seat when treating a pediatric patient is in the extended position while the occupant enters and exits the mono medical hyperbaric oxygen chamber and the seat is returned to the fixed position inside the hyperbaric oxygen chamber while the overhead door is closed. The hyperbaric oxygen chamber is made using additive manufacturing technology and can fit into the office of a physician.

Devices, systems, and methods to treat an environment. The device includes a scent control material source. The device can also include a dehumidifier, humidifier, and one or more fans. The scent control material device is configured to output a scent control material (e.g., an oxidant) into the environment to reduce pathogens, dispose of scent molecules and their sources, and otherwise treat the environment. The device can include a controller communicatively coupled to the scent control material source, dehumidifier, humidifier, and one or more fans. The controller can implement operational programs dictating at least one output of the device. The device can also function in a cyclical or periodic mode in which an output of the device can be varied to more effectively treat the environment. In examples, the controller can operate in conjunction with a remote control to regulate output parameters of the device.

Devices, systems, and methods to treat an environment. The device includes a scent control material source. The device can also include a dehumidifier, humidifier, and one or more fans. The scent control material device is configured to output a scent control material (e.g., an oxidant) into the environment to reduce pathogens, dispose of scent molecules and their sources, and otherwise treat the environment. The device can include a controller communicatively coupled to the scent control material source, dehumidifier, humidifier, and one or more fans. The controller can implement operational programs dictating at least one output of the device. The device can also function in a cyclical or periodic mode in which an output of the device can be varied to more effectively treat the environment. In examples, the controller can operate in conjunction with a remote control to regulate output parameters of the device.

The present invention relates to an improved device for supplying temperature controlled laminar air flow (TLA) of filtered air to generate a clean air zone, e.g. a controlled personal breathing zone, at a point of care. The specific relative placement of the air inlets and outlets of the device of the present invention enables the provision of a more stable TLA based clean air zone than the prior art devices and at the same time allows for extensive monitoring and reporting features.

The present invention relates to an improved device for supplying temperature controlled laminar air flow (TLA) of filtered air to generate a clean air zone, e.g. a controlled personal breathing zone, at a point of care. The specific relative placement of the air inlets and outlets of the device of the present invention enables the provision of a more stable TLA based clean air zone than the prior art devices and at the same time allows for extensive monitoring and reporting features.